- StandardsNational Standards
- HealthcareMonitor, Inform, HTA
- » Focus on quality and safety
- » Find a centre
- » Health Technology Assessement
- » Informing decision making
- » Useful links
- » Frequently asked questions
- Social care
- » Using care services
- » Find a centre
- » Children and Young People
- » Older people
- » People with disabilities
- » Useful links
- » Frequently asked questions
- Getting involvedConsultations
A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt-Jakob disease transmission in Ireland
Date of publication:Wednesday, July 27, 2011
This health technology assessment (HTA) examined the potential for a new technology, prion filtration, to reduce the risk of variant Creutzfeldt-Jakob disease (vCJD) transmission from the transfusion of red cell concentrates (RCC) in Ireland.
- HealthcareMonitor, Inform, HTA
